查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1867511

真菌感染疾病診斷：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Fungal Infection Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球真菌感染疾病診斷市場預計在 2024 年達到 1.25 億美元，預計到 2031 年將達到 2.81 億美元，2025 年至 2031 年的複合年成長率為 12.5%。

侵襲性真菌感染疾病（IFD）是由真菌侵入人體組織和血液引起的嚴重感染疾病，會導致組織損傷、器官功能障礙和發炎反應。 IFD在免疫力缺乏患者中特別常見，例如器官移植受者和癌症患者，發生率高達20%至40%。 IFD是這些患者群體的主要死因之一。為了實現早期診斷和有效治療，全球大多數醫院都採用了非侵入性實驗室診斷技術，例如革蘭氏陽性菌（G）和革蘭氏陰性菌（GM）檢測。本報告涵蓋了真菌感染疾病診斷中使用的儀器和試劑，並重點介紹了革蘭氏陽性菌（G）和革蘭氏陰性菌（GM）檢測的方法。

侵襲性真菌疾病（IFD）在免疫力缺乏患者中發病率較高，早期診斷仍是一項挑戰。目前，G試驗和GM試驗等非侵入性檢測方法已在全球廣泛用於真菌感染疾病的早期檢測。這些方法檢測血清中的真菌抗原，提供了相對快速且非侵入性的診斷工具，尤其適用於免疫抑制患者。然而，儘管這些診斷方法應用廣泛，但其敏感性和特異性有限，且對操作人員的技術水平要求較高。此外，一些地區設備和試劑的供應仍然不足，阻礙了其在全球範圍內的廣泛應用。因此，提高診斷方法的準確性、降低成本並擴大其全球應用仍然是極待解決的挑戰。分子生物學、人工智慧和數位病理學的進步正推動真菌感染疾病診斷領域朝著更高的效率、準確性和智慧化方向發展。例如，將深度學習演算法應用於顯微影像，無需染色即可實現快速且準確的檢測，從而顯著提高診斷效率和準確性。此外，數位病理影像資料資料庫的建構為真菌感染疾病的自動化檢測和分類提供了豐富的數據支持，促進了該領域的研究和應用。未來，融合人工智慧和分子診斷技術的診斷平台有望成為真菌感染疾病診斷的主流，提供更全面、快速、準確的診斷服務。推動真菌感染疾病診斷技術發展的主要動力是早期診斷和精準治療的迫切需求。早期診斷和適當治療對於提高存活率至關重要，尤其對於免疫抑制患者。然而，技術進步面臨許多挑戰。首先，先進診斷設備和試劑的高成本可能限制其在資源匱乏地區的應用。其次，人工智慧和數位病理技術的引入需要大量高品質數據，但此類數據的獲取和共用會帶來隱私和倫理方面的挑戰。最後，這些技術的廣泛應用需要相應的培訓和教育，以確保操作人員掌握新技術。因此，解決成本、資料共用和人力資源開發等挑戰將是該領域發展的關鍵。

本報告旨在按地區/國家、類型和應用對全球真菌感染疾病診斷市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本報告以收益為準，對真菌感染疾病診斷市場規模、估計值和預測進行了呈現，以2024年為基準年，並涵蓋了2020年至2031年的歷史數據和預測數據。透過定量和定性分析，我們幫助讀者制定真菌感染疾病診斷業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • Associates of Cape Cod
  • Bio-Rad
  • IMMY
  • BioMerieux
  • Fujifilm Wako Pure Chemica
  • Era Biology
  • Dynamiker Biotechnology
  • Zhanjiang A&C Biological
  • Xiamen Bioendo Technology
  • Zhanjiang Bokang Marine Biological
  • Fuzhou XinBei Biochemical Industrial
  • Zhuhai DL Biotech
  • Autobio Diagnostics

按類型分類的細分市場

  • 半乳甘露聚醣測試
  • （1->3）- BETA-D-聚葡萄糖測試

應用領域

  • 醫院
  • 檢查室

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Fungal Infection Diagnosis was estimated to be worth US$ 125 million in 2024 and is forecast to a readjusted size of US$ 281 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.

Invasive fungal disease (IFD) refers to severe infections caused by fungi invading human tissues and bloodstream, leading to tissue damage, organ dysfunction, and inflammatory responses. It is especially prevalent among immunocompromised patients such as organ transplant recipients and cancer patients, with an incidence rate of 20% to 40%, becoming a significant cause of mortality in these populations. To enable early diagnosis and effective treatment, most hospitals worldwide have adopted non-invasive laboratory diagnostic techniques such as the G test and GM test. This report covers the equipment and reagents used for fungal infection diagnosis, specifically focusing on G test and GM test methodologies.

Invasive fungal diseases (IFDs) have a high incidence among immunocompromised patients, and early diagnosis remains challenging. Currently, non-invasive laboratory diagnostic techniques such as the G test and GM test are widely used globally for early detection of fungal infections. These methods detect fungal antigens in serum, providing relatively rapid and non-invasive diagnostic options, especially suitable for immunosuppressed patients. However, despite their widespread adoption, these diagnostic methods still have limitations in sensitivity and specificity, and require high technical expertise from operators. Additionally, in some regions, the availability of equipment and reagents is still insufficient, limiting their global accessibility. Therefore, improving the accuracy of diagnostic methods, reducing costs, and expanding their availability worldwide remain pressing issues.With advancements in molecular biology, artificial intelligence, and digital pathology, the field of fungal infection diagnosis is moving towards higher efficiency, precision, and intelligence. For instance, deep learning algorithms have been applied to automatically classify and identify fungal species in microscopic images, enabling rapid and accurate detection without the need for staining, significantly improving diagnostic efficiency and accuracy. Moreover, the establishment of digital pathology image databases provides rich data support for automated detection and classification of fungal infections, promoting research and application in this field. In the future, integrated diagnostic platforms combining artificial intelligence and molecular diagnostic technologies are expected to become mainstream in fungal infection diagnosis, offering more comprehensive, rapid, and accurate diagnostic services.The primary driver for the development of fungal infection diagnostic technologies is the urgent need for early diagnosis and precise treatment. Especially among immunosuppressed patients, early diagnosis and timely treatment are crucial for improving survival rates. However, technological advancements face several barriers. Firstly, the high cost of advanced diagnostic equipment and reagents may limit their application in resource-limited areas. Secondly, the application of artificial intelligence and digital pathology technologies requires large amounts of high-quality data, and the acquisition and sharing of such data face challenges related to privacy protection and ethical issues. Lastly, the promotion and application of these technologies require corresponding training and education to ensure operators can proficiently master new technologies. Therefore, addressing issues such as cost, data sharing, and personnel training will be key to advancing this field.

This report aims to provide a comprehensive presentation of the global market for Fungal Infection Diagnosis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Fungal Infection Diagnosis by region & country, by Type, and by Application.

The Fungal Infection Diagnosis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fungal Infection Diagnosis.

Market Segmentation

By Company

  • Associates of Cape Cod
  • Bio-Rad
  • IMMY
  • BioMerieux
  • Fujifilm Wako Pure Chemica
  • Era Biology
  • Dynamiker Biotechnology
  • Zhanjiang A&C Biological
  • Xiamen Bioendo Technology
  • Zhanjiang Bokang Marine Biological
  • Fuzhou XinBei Biochemical Industrial
  • Zhuhai DL Biotech
  • Autobio Diagnostics

Segment by Type

  • Galactomannan Test
  • (1->3)-B-D Glucan Test

Segment by Application

  • Hospital
  • Laboratory

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Fungal Infection Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Fungal Infection Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Fungal Infection Diagnosis in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Fungal Infection Diagnosis Product Introduction
  • 1.2 Global Fungal Infection Diagnosis Market Size Forecast (2020-2031)
  • 1.3 Fungal Infection Diagnosis Market Trends & Drivers
    • 1.3.1 Fungal Infection Diagnosis Industry Trends
    • 1.3.2 Fungal Infection Diagnosis Market Drivers & Opportunity
    • 1.3.3 Fungal Infection Diagnosis Market Challenges
    • 1.3.4 Fungal Infection Diagnosis Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Fungal Infection Diagnosis Players Revenue Ranking (2024)
  • 2.2 Global Fungal Infection Diagnosis Revenue by Company (2020-2025)
  • 2.3 Key Companies Fungal Infection Diagnosis Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Fungal Infection Diagnosis Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Fungal Infection Diagnosis
  • 2.6 Fungal Infection Diagnosis Market Competitive Analysis
    • 2.6.1 Fungal Infection Diagnosis Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Fungal Infection Diagnosis Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fungal Infection Diagnosis as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Galactomannan Test
    • 3.1.2 (1->3)-B-D Glucan Test
  • 3.2 Global Fungal Infection Diagnosis Sales Value by Type
    • 3.2.1 Global Fungal Infection Diagnosis Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Fungal Infection Diagnosis Sales Value, by Type (2020-2031)
    • 3.2.3 Global Fungal Infection Diagnosis Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Laboratory
  • 4.2 Global Fungal Infection Diagnosis Sales Value by Application
    • 4.2.1 Global Fungal Infection Diagnosis Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Fungal Infection Diagnosis Sales Value, by Application (2020-2031)
    • 4.2.3 Global Fungal Infection Diagnosis Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Fungal Infection Diagnosis Sales Value by Region
    • 5.1.1 Global Fungal Infection Diagnosis Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Fungal Infection Diagnosis Sales Value by Region (2020-2025)
    • 5.1.3 Global Fungal Infection Diagnosis Sales Value by Region (2026-2031)
    • 5.1.4 Global Fungal Infection Diagnosis Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Fungal Infection Diagnosis Sales Value, 2020-2031
    • 5.2.2 North America Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Fungal Infection Diagnosis Sales Value, 2020-2031
    • 5.3.2 Europe Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Fungal Infection Diagnosis Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Fungal Infection Diagnosis Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Fungal Infection Diagnosis Sales Value, 2020-2031
    • 5.5.2 South America Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Fungal Infection Diagnosis Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Fungal Infection Diagnosis Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Fungal Infection Diagnosis Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.3.2 United States Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.4.2 Europe Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.5.2 China Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.6.2 Japan Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.7.2 South Korea Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Fungal Infection Diagnosis Sales Value, 2020-2031
    • 6.9.2 India Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Fungal Infection Diagnosis Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Associates of Cape Cod
    • 7.1.1 Associates of Cape Cod Profile
    • 7.1.2 Associates of Cape Cod Main Business
    • 7.1.3 Associates of Cape Cod Fungal Infection Diagnosis Products, Services and Solutions
    • 7.1.4 Associates of Cape Cod Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Associates of Cape Cod Recent Developments
  • 7.2 Bio-Rad
    • 7.2.1 Bio-Rad Profile
    • 7.2.2 Bio-Rad Main Business
    • 7.2.3 Bio-Rad Fungal Infection Diagnosis Products, Services and Solutions
    • 7.2.4 Bio-Rad Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Bio-Rad Recent Developments
  • 7.3 IMMY
    • 7.3.1 IMMY Profile
    • 7.3.2 IMMY Main Business
    • 7.3.3 IMMY Fungal Infection Diagnosis Products, Services and Solutions
    • 7.3.4 IMMY Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.3.5 IMMY Recent Developments
  • 7.4 BioMerieux
    • 7.4.1 BioMerieux Profile
    • 7.4.2 BioMerieux Main Business
    • 7.4.3 BioMerieux Fungal Infection Diagnosis Products, Services and Solutions
    • 7.4.4 BioMerieux Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.4.5 BioMerieux Recent Developments
  • 7.5 Fujifilm Wako Pure Chemica
    • 7.5.1 Fujifilm Wako Pure Chemica Profile
    • 7.5.2 Fujifilm Wako Pure Chemica Main Business
    • 7.5.3 Fujifilm Wako Pure Chemica Fungal Infection Diagnosis Products, Services and Solutions
    • 7.5.4 Fujifilm Wako Pure Chemica Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Fujifilm Wako Pure Chemica Recent Developments
  • 7.6 Era Biology
    • 7.6.1 Era Biology Profile
    • 7.6.2 Era Biology Main Business
    • 7.6.3 Era Biology Fungal Infection Diagnosis Products, Services and Solutions
    • 7.6.4 Era Biology Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Era Biology Recent Developments
  • 7.7 Dynamiker Biotechnology
    • 7.7.1 Dynamiker Biotechnology Profile
    • 7.7.2 Dynamiker Biotechnology Main Business
    • 7.7.3 Dynamiker Biotechnology Fungal Infection Diagnosis Products, Services and Solutions
    • 7.7.4 Dynamiker Biotechnology Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Dynamiker Biotechnology Recent Developments
  • 7.8 Zhanjiang A&C Biological
    • 7.8.1 Zhanjiang A&C Biological Profile
    • 7.8.2 Zhanjiang A&C Biological Main Business
    • 7.8.3 Zhanjiang A&C Biological Fungal Infection Diagnosis Products, Services and Solutions
    • 7.8.4 Zhanjiang A&C Biological Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Zhanjiang A&C Biological Recent Developments
  • 7.9 Xiamen Bioendo Technology
    • 7.9.1 Xiamen Bioendo Technology Profile
    • 7.9.2 Xiamen Bioendo Technology Main Business
    • 7.9.3 Xiamen Bioendo Technology Fungal Infection Diagnosis Products, Services and Solutions
    • 7.9.4 Xiamen Bioendo Technology Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Xiamen Bioendo Technology Recent Developments
  • 7.10 Zhanjiang Bokang Marine Biological
    • 7.10.1 Zhanjiang Bokang Marine Biological Profile
    • 7.10.2 Zhanjiang Bokang Marine Biological Main Business
    • 7.10.3 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Products, Services and Solutions
    • 7.10.4 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Zhanjiang Bokang Marine Biological Recent Developments
  • 7.11 Fuzhou XinBei Biochemical Industrial
    • 7.11.1 Fuzhou XinBei Biochemical Industrial Profile
    • 7.11.2 Fuzhou XinBei Biochemical Industrial Main Business
    • 7.11.3 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Products, Services and Solutions
    • 7.11.4 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Fuzhou XinBei Biochemical Industrial Recent Developments
  • 7.12 Zhuhai DL Biotech
    • 7.12.1 Zhuhai DL Biotech Profile
    • 7.12.2 Zhuhai DL Biotech Main Business
    • 7.12.3 Zhuhai DL Biotech Fungal Infection Diagnosis Products, Services and Solutions
    • 7.12.4 Zhuhai DL Biotech Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Zhuhai DL Biotech Recent Developments
  • 7.13 Autobio Diagnostics
    • 7.13.1 Autobio Diagnostics Profile
    • 7.13.2 Autobio Diagnostics Main Business
    • 7.13.3 Autobio Diagnostics Fungal Infection Diagnosis Products, Services and Solutions
    • 7.13.4 Autobio Diagnostics Fungal Infection Diagnosis Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Autobio Diagnostics Recent Developments

8 Industry Chain Analysis

  • 8.1 Fungal Infection Diagnosis Industrial Chain
  • 8.2 Fungal Infection Diagnosis Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Fungal Infection Diagnosis Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Fungal Infection Diagnosis Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Fungal Infection Diagnosis Market Trends
  • Table 2. Fungal Infection Diagnosis Market Drivers & Opportunity
  • Table 3. Fungal Infection Diagnosis Market Challenges
  • Table 4. Fungal Infection Diagnosis Market Restraints
  • Table 5. Global Fungal Infection Diagnosis Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Fungal Infection Diagnosis Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Fungal Infection Diagnosis Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Fungal Infection Diagnosis Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Fungal Infection Diagnosis
  • Table 10. Global Fungal Infection Diagnosis Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fungal Infection Diagnosis as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Fungal Infection Diagnosis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Fungal Infection Diagnosis Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Fungal Infection Diagnosis Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Fungal Infection Diagnosis Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Fungal Infection Diagnosis Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Fungal Infection Diagnosis Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Fungal Infection Diagnosis Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Fungal Infection Diagnosis Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Fungal Infection Diagnosis Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Fungal Infection Diagnosis Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Fungal Infection Diagnosis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Fungal Infection Diagnosis Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Fungal Infection Diagnosis Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Fungal Infection Diagnosis Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Fungal Infection Diagnosis Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Fungal Infection Diagnosis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Fungal Infection Diagnosis Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Fungal Infection Diagnosis Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Associates of Cape Cod Basic Information List
  • Table 32. Associates of Cape Cod Description and Business Overview
  • Table 33. Associates of Cape Cod Fungal Infection Diagnosis Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Associates of Cape Cod (2020-2025)
  • Table 35. Associates of Cape Cod Recent Developments
  • Table 36. Bio-Rad Basic Information List
  • Table 37. Bio-Rad Description and Business Overview
  • Table 38. Bio-Rad Fungal Infection Diagnosis Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Bio-Rad (2020-2025)
  • Table 40. Bio-Rad Recent Developments
  • Table 41. IMMY Basic Information List
  • Table 42. IMMY Description and Business Overview
  • Table 43. IMMY Fungal Infection Diagnosis Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Fungal Infection Diagnosis Business of IMMY (2020-2025)
  • Table 45. IMMY Recent Developments
  • Table 46. BioMerieux Basic Information List
  • Table 47. BioMerieux Description and Business Overview
  • Table 48. BioMerieux Fungal Infection Diagnosis Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Fungal Infection Diagnosis Business of BioMerieux (2020-2025)
  • Table 50. BioMerieux Recent Developments
  • Table 51. Fujifilm Wako Pure Chemica Basic Information List
  • Table 52. Fujifilm Wako Pure Chemica Description and Business Overview
  • Table 53. Fujifilm Wako Pure Chemica Fungal Infection Diagnosis Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Fujifilm Wako Pure Chemica (2020-2025)
  • Table 55. Fujifilm Wako Pure Chemica Recent Developments
  • Table 56. Era Biology Basic Information List
  • Table 57. Era Biology Description and Business Overview
  • Table 58. Era Biology Fungal Infection Diagnosis Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Era Biology (2020-2025)
  • Table 60. Era Biology Recent Developments
  • Table 61. Dynamiker Biotechnology Basic Information List
  • Table 62. Dynamiker Biotechnology Description and Business Overview
  • Table 63. Dynamiker Biotechnology Fungal Infection Diagnosis Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Dynamiker Biotechnology (2020-2025)
  • Table 65. Dynamiker Biotechnology Recent Developments
  • Table 66. Zhanjiang A&C Biological Basic Information List
  • Table 67. Zhanjiang A&C Biological Description and Business Overview
  • Table 68. Zhanjiang A&C Biological Fungal Infection Diagnosis Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Zhanjiang A&C Biological (2020-2025)
  • Table 70. Zhanjiang A&C Biological Recent Developments
  • Table 71. Xiamen Bioendo Technology Basic Information List
  • Table 72. Xiamen Bioendo Technology Description and Business Overview
  • Table 73. Xiamen Bioendo Technology Fungal Infection Diagnosis Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Xiamen Bioendo Technology (2020-2025)
  • Table 75. Xiamen Bioendo Technology Recent Developments
  • Table 76. Zhanjiang Bokang Marine Biological Basic Information List
  • Table 77. Zhanjiang Bokang Marine Biological Description and Business Overview
  • Table 78. Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Zhanjiang Bokang Marine Biological (2020-2025)
  • Table 80. Zhanjiang Bokang Marine Biological Recent Developments
  • Table 81. Fuzhou XinBei Biochemical Industrial Basic Information List
  • Table 82. Fuzhou XinBei Biochemical Industrial Description and Business Overview
  • Table 83. Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Fuzhou XinBei Biochemical Industrial (2020-2025)
  • Table 85. Fuzhou XinBei Biochemical Industrial Recent Developments
  • Table 86. Zhuhai DL Biotech Basic Information List
  • Table 87. Zhuhai DL Biotech Description and Business Overview
  • Table 88. Zhuhai DL Biotech Fungal Infection Diagnosis Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Zhuhai DL Biotech (2020-2025)
  • Table 90. Zhuhai DL Biotech Recent Developments
  • Table 91. Autobio Diagnostics Basic Information List
  • Table 92. Autobio Diagnostics Description and Business Overview
  • Table 93. Autobio Diagnostics Fungal Infection Diagnosis Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Fungal Infection Diagnosis Business of Autobio Diagnostics (2020-2025)
  • Table 95. Autobio Diagnostics Recent Developments
  • Table 96. Key Raw Materials Lists
  • Table 97. Raw Materials Key Suppliers Lists
  • Table 98. Fungal Infection Diagnosis Downstream Customers
  • Table 99. Fungal Infection Diagnosis Distributors List
  • Table 100. Research Programs/Design for This Report
  • Table 101. Key Data Information from Secondary Sources
  • Table 102. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Fungal Infection Diagnosis Product Picture
  • Figure 2. Global Fungal Infection Diagnosis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Fungal Infection Diagnosis Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Fungal Infection Diagnosis Report Years Considered
  • Figure 5. Global Fungal Infection Diagnosis Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Fungal Infection Diagnosis Revenue in 2024
  • Figure 7. Fungal Infection Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Galactomannan Test Picture
  • Figure 9. (1->3)-B-D Glucan Test Picture
  • Figure 10. Global Fungal Infection Diagnosis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Fungal Infection Diagnosis Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Hospital
  • Figure 13. Product Picture of Laboratory
  • Figure 14. Global Fungal Infection Diagnosis Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Fungal Infection Diagnosis Sales Value Market Share by Application, 2024 & 2031
  • Figure 16. North America Fungal Infection Diagnosis Sales Value (2020-2031) & (US$ Million)
  • Figure 17. North America Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • Figure 18. Europe Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 19. Europe Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • Figure 20. Asia Pacific Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. Asia Pacific Fungal Infection Diagnosis Sales Value by Region (%), 2024 VS 2031
  • Figure 22. South America Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. South America Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Middle East & Africa Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Middle East & Africa Fungal Infection Diagnosis Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Key Countries/Regions Fungal Infection Diagnosis Sales Value (%), (2020-2031)
  • Figure 27. United States Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. United States Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 29. United States Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 30. Europe Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Europe Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 32. Europe Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 33. China Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. China Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 35. China Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 36. Japan Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. Japan Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 38. Japan Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 39. South Korea Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. South Korea Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 41. South Korea Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Southeast Asia Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Southeast Asia Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Southeast Asia Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 45. India Fungal Infection Diagnosis Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. India Fungal Infection Diagnosis Sales Value by Type (%), 2024 VS 2031
  • Figure 47. India Fungal Infection Diagnosis Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Fungal Infection Diagnosis Industrial Chain
  • Figure 49. Fungal Infection Diagnosis Manufacturing Cost Structure
  • Figure 50. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 51. Bottom-up and Top-down Approaches for This Report
  • Figure 52. Data Triangulation
  • Figure 53. Key Executives Interviewed